Details of the Drug

General Information of Drug (ID: DMOPRQ7)

Drug Name

4-[3-(3-benzyloxy-pyridin-2-yl)-ureido]-benzamide

Synonyms

CHEMBL201718; 4-[3-(3-benzyloxy-pyridin-2-yl)-ureido]-benzamide; BDBM50181477; 4-[(3-benzyloxy-2-pyridyl)carbamoylamino]benzamide; Benzamide, 4-[[[[3-(phenylmethoxy)-2-pyridinyl]amino]carbonyl]amino]-

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

362.4

Logarithm of the Partition Coefficient (xlogp)

2.1

Rotatable Bond Count (rotbonds)

6

Hydrogen Bond Donor Count (hbonddonor)

3

Hydrogen Bond Acceptor Count (hbondacc)

4

Chemical Identifiers

Formula: C20H18N4O3
IUPAC Name: 4-[(3-phenylmethoxypyridin-2-yl)carbamoylamino]benzamide
Canonical SMILES: C1=CC=C(C=C1)COC2=C(N=CC=C2)NC(=O)NC3=CC=C(C=C3)C(=O)N
InChI: InChI=1S/C20H18N4O3/c21-18(25)15-8-10-16(11-9-15)23-20(26)24-19-17(7-4-12-22-19)27-13-14-5-2-1-3-6-14/h1-12H,13H2,(H2,21,25)(H2,22,23,24,26)
InChIKey: TWCYUPDQSZQMLM-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 11574097
TTD ID: D0X5JR

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Rotamase A (PPIA)	TTL2ADK	PPIA_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A. J Med Chem. 2006 Feb 9;49(3):900-10.